160 related articles for article (PubMed ID: 31097990)
1. 2-Aminothiazole-4-carboxamides Enhance Readthrough of Premature Termination Codons by Aminoglycosides.
Rabea SM; Baradaran-Heravi A; Balgi AD; Krause A; Hosseini Farahabadi S; Roberge M; Grierson DS
ACS Med Chem Lett; 2019 May; 10(5):726-731. PubMed ID: 31097990
[TBL] [Abstract][Full Text] [Related]
2. Novel small molecules potentiate premature termination codon readthrough by aminoglycosides.
Baradaran-Heravi A; Balgi AD; Zimmerman C; Choi K; Shidmoossavee FS; Tan JS; Bergeaud C; Krause A; Flibotte S; Shimizu Y; Anderson HJ; Mouly V; Jan E; Pfeifer T; Jaquith JB; Roberge M
Nucleic Acids Res; 2016 Aug; 44(14):6583-98. PubMed ID: 27407112
[TBL] [Abstract][Full Text] [Related]
3. Small molecule Y-320 stimulates ribosome biogenesis, protein synthesis, and aminoglycoside-induced premature termination codon readthrough.
Hosseini-Farahabadi S; Baradaran-Heravi A; Zimmerman C; Choi K; Flibotte S; Roberge M
PLoS Biol; 2021 May; 19(5):e3001221. PubMed ID: 33939688
[TBL] [Abstract][Full Text] [Related]
4. Stop codon context influences genome-wide stimulation of termination codon readthrough by aminoglycosides.
Wangen JR; Green R
Elife; 2020 Jan; 9():. PubMed ID: 31971508
[TBL] [Abstract][Full Text] [Related]
5. The antimalarial drug mefloquine enhances TP53 premature termination codon readthrough by aminoglycoside G418.
Ferguson MW; Gerak CAN; Chow CCT; Rastelli EJ; Elmore KE; Stahl F; Hosseini-Farahabadi S; Baradaran-Heravi A; Coltart DM; Roberge M
PLoS One; 2019; 14(5):e0216423. PubMed ID: 31120902
[TBL] [Abstract][Full Text] [Related]
6. Effect of small molecule eRF3 degraders on premature termination codon readthrough.
Baradaran-Heravi A; Balgi AD; Hosseini-Farahabadi S; Choi K; Has C; Roberge M
Nucleic Acids Res; 2021 Apr; 49(7):3692-3708. PubMed ID: 33764477
[TBL] [Abstract][Full Text] [Related]
7. Aminoglycoside-stimulated readthrough of premature termination codons in selected genes involved in primary ciliary dyskinesia.
Bukowy-Bieryllo Z; Dabrowski M; Witt M; Zietkiewicz E
RNA Biol; 2016 Oct; 13(10):1041-1050. PubMed ID: 27618201
[TBL] [Abstract][Full Text] [Related]
8. Properties of Non-Aminoglycoside Compounds Used to Stimulate Translational Readthrough of PTC Mutations in Primary Ciliary Dyskinesia.
Dabrowski M; Bukowy-Bieryllo Z; Jackson CL; Zietkiewicz E
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34066907
[TBL] [Abstract][Full Text] [Related]
9. Functional Restoration of
Abreu RBV; Gomes TT; Nepomuceno TC; Li X; Fuchshuber-Moraes M; De Gregoriis G; Suarez-Kurtz G; Monteiro ANA; Carvalho MA
Front Pharmacol; 2022; 13():935995. PubMed ID: 35837282
[TBL] [Abstract][Full Text] [Related]
10. Aminoglycosides are efficient reagents to induce readthrough of premature termination codon in mutant B4GALNT1 genes found in families of hereditary spastic paraplegia.
Yesmin F; Bhuiyan RH; Ohmi Y; Ohkawa Y; Tajima O; Okajima T; Furukawa K; Furukawa K
J Biochem; 2020 Aug; 168(2):103-112. PubMed ID: 32282910
[TBL] [Abstract][Full Text] [Related]
11. Pharmaceuticals Promoting Premature Termination Codon Readthrough: Progress in Development.
Li S; Li J; Shi W; Nie Z; Zhang S; Ma F; Hu J; Chen J; Li P; Xie X
Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371567
[TBL] [Abstract][Full Text] [Related]
12. Gentamicin B1 is a minor gentamicin component with major nonsense mutation suppression activity.
Baradaran-Heravi A; Niesser J; Balgi AD; Choi K; Zimmerman C; South AP; Anderson HJ; Strynadka NC; Bally MB; Roberge M
Proc Natl Acad Sci U S A; 2017 Mar; 114(13):3479-3484. PubMed ID: 28289221
[TBL] [Abstract][Full Text] [Related]
13. Characterization of new-generation aminoglycoside promoting premature termination codon readthrough in cancer cells.
Bidou L; Bugaud O; Belakhov V; Baasov T; Namy O
RNA Biol; 2017 Mar; 14(3):378-388. PubMed ID: 28145797
[TBL] [Abstract][Full Text] [Related]
14. Nonselective TRPC channel inhibition and suppression of aminoglycoside-induced premature termination codon readthrough by the small molecule AC1903.
Baradaran-Heravi A; Bauer CC; Pickles IB; Hosseini-Farahabadi S; Balgi AD; Choi K; Linley DM; Beech DJ; Roberge M; Bon RS
J Biol Chem; 2022 Feb; 298(2):101546. PubMed ID: 34999117
[TBL] [Abstract][Full Text] [Related]
15. Guanidino quinazolines and pyrimidines promote readthrough of premature termination codons in cells with native nonsense mutations.
Morrill C; Friesen WJ; Babu S; Baiazitov RY; Du W; Karloff DB; Lee CS; Moon YC; Ren H; Sierra J; Tomizawa Y; Vazirani P; Welch EM; Xue X; Zhuo J
Bioorg Med Chem Lett; 2022 Nov; 76():128989. PubMed ID: 36150638
[TBL] [Abstract][Full Text] [Related]
16. Serum starvation enhances nonsense mutation readthrough.
Wittenstein A; Caspi M; David Y; Shorer Y; Nadar-Ponniah PT; Rosin-Arbesfeld R
J Mol Med (Berl); 2019 Dec; 97(12):1695-1710. PubMed ID: 31786671
[TBL] [Abstract][Full Text] [Related]
17. Novel compounds that synergize with aminoglycoside G418 or eRF3 degraders for translational readthrough of nonsense mutant
Heldin A; Cancer M; Palomar-Siles M; Öhlin S; Zhang M; Sun-Zhang A; Mariani A; Liu J; Bykov VJN; Wiman KG
RNA Biol; 2023 Jan; 20(1):368-383. PubMed ID: 37339263
[TBL] [Abstract][Full Text] [Related]
18. Readthrough of stop codons by use of aminoglycosides in cells from xeroderma pigmentosum group C patients.
Kuschal C; Khan SG; Enk B; DiGiovanna JJ; Kraemer KH
Exp Dermatol; 2015 Apr; 24(4):296-7. PubMed ID: 25651777
[TBL] [Abstract][Full Text] [Related]
19. The minor gentamicin complex component, X2, is a potent premature stop codon readthrough molecule with therapeutic potential.
Friesen WJ; Johnson B; Sierra J; Zhuo J; Vazirani P; Xue X; Tomizawa Y; Baiazitov R; Morrill C; Ren H; Babu S; Moon YC; Branstrom A; Mollin A; Hedrick J; Sheedy J; Elfring G; Weetall M; Colacino JM; Welch EM; Peltz SW
PLoS One; 2018; 13(10):e0206158. PubMed ID: 30359426
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic targeting of
Strandgren C; Wiman KG
Ups J Med Sci; 2024; 129():. PubMed ID: 38863730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
